AU2003295393A8 - Ghb treatment methods - Google Patents

Ghb treatment methods

Info

Publication number
AU2003295393A8
AU2003295393A8 AU2003295393A AU2003295393A AU2003295393A8 AU 2003295393 A8 AU2003295393 A8 AU 2003295393A8 AU 2003295393 A AU2003295393 A AU 2003295393A AU 2003295393 A AU2003295393 A AU 2003295393A AU 2003295393 A8 AU2003295393 A8 AU 2003295393A8
Authority
AU
Australia
Prior art keywords
treatment methods
ghb treatment
ghb
methods
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003295393A
Other versions
AU2003295393A1 (en
Inventor
Damon A Anderson
Teodoro G Bottiglieri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor Research Institute
Original Assignee
Baylor Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor Research Institute filed Critical Baylor Research Institute
Publication of AU2003295393A8 publication Critical patent/AU2003295393A8/en
Publication of AU2003295393A1 publication Critical patent/AU2003295393A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003295393A 2002-11-01 2003-11-03 Ghb treatment methods Abandoned AU2003295393A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42308302P 2002-11-01 2002-11-01
US60/423,083 2002-11-01
PCT/US2003/035156 WO2004041207A2 (en) 2002-11-01 2003-11-03 Ghb treatment methods

Publications (2)

Publication Number Publication Date
AU2003295393A8 true AU2003295393A8 (en) 2004-06-07
AU2003295393A1 AU2003295393A1 (en) 2004-06-07

Family

ID=32312601

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003295393A Abandoned AU2003295393A1 (en) 2002-11-01 2003-11-03 Ghb treatment methods

Country Status (2)

Country Link
AU (1) AU2003295393A1 (en)
WO (1) WO2004041207A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006016990A1 (en) * 2006-04-11 2007-10-18 Hermann, Holger Lars, Dr. Use of baclofen compounds to treat dependence on gamma-hydroxybutyrate or its analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2023421A (en) * 1978-06-22 1980-01-03 Grissmann Chem Ltd gamma -Butyrolactone for therapy of insomnia and anxiety
IT1266565B1 (en) * 1993-07-22 1997-01-09 Ct Lab Farm Srl PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE ON THE BASIS OF ONE OR MORE PHARMACEUTICALLY ACCEPTABLE SALTS OF THE RANGE-HYDROXY-BUTYRIC ACID.
IT1283782B1 (en) * 1996-08-09 1998-04-30 Ct Lab Farm Srl USE OF AMIDES OF GAMMA-HYDROXYBUTYRIC ACID IN THE TREATMENT OF TOXIC ADDICTION, AND IN PARTICULAR IN ALCOHOLISM

Also Published As

Publication number Publication date
WO2004041207A3 (en) 2005-01-20
WO2004041207A2 (en) 2004-05-21
AU2003295393A1 (en) 2004-06-07

Similar Documents

Publication Publication Date Title
GB0210143D0 (en) Process
EP1575495A4 (en) Compounds and methods
GB0205016D0 (en) Process
GB0201505D0 (en) Process
GB0204607D0 (en) Process
GB0221574D0 (en) Treatments
GB0205014D0 (en) Process
GB0202564D0 (en) Process
GB0208928D0 (en) Methods
GB0220045D0 (en) Methods
GB0221157D0 (en) Novel treatment
GB0130763D0 (en) Treatment methods
GB0201378D0 (en) Process
GB0221711D0 (en) Methods
GB0202563D0 (en) Process
AU2003295393A8 (en) Ghb treatment methods
GB0204967D0 (en) Methods
GB0219723D0 (en) Methods
GB0202213D0 (en) Methods
GB0222276D0 (en) Methods
AU2003231937A8 (en) Therapeutic methods
GB0203665D0 (en) Process
GB0213580D0 (en) Methods
GB0213579D0 (en) Methods
GB0200526D0 (en) Methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase